Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.470
-0.060-2.37%
Volume:82.09K
Turnover:198.13K
Market Cap:1.53B
PE:-6.80
High:2.470
Open:2.400
Low:2.380
Close:2.530
52wk High:6.150
52wk Low:2.270
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:0.48
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.363
ROE:-242.61%
ROA:-17.94%
PB:-9.49
PE(LYR):-6.80
PS:- -

Loading ...

Record $8.85 Billion Deal Ignites Pharma Sector, ETF Tops 2.75% Gain

Deep News
·
2 hours ago

Chinese Biotech Leader Surges Nearly 7% on $8.8 Billion Partnership with Global Pharma Giant

Deep News
·
7 hours ago

Zhongsheng Pharma's Novel Drug Project Achieves Topline Results in Two Phase III Trials

Stock News
·
Yesterday

Overseas Expansion Wave of Innovative Drugs Persists, Hong Kong Biotech ETF Rises 1.18%

Deep News
·
Feb 06

GTHT Securities: Risk Appetite for Innovative Drug Sector Shows Clear Recovery, Policy, M&A, and R&D Synergies Catalyze Structural Opportunities

Stock News
·
Feb 06

Traditional Chinese Medicine Industry Embarks on Five-Year Golden Era: Plans to Cultivate 10 Major Drug Varieties and Promote Approvals for Innovative Medicines

Deep News
·
Feb 06

Over 80% of Innovative Drugs Included in National Medical Insurance Within Two Years, Generic Drugs Enter Era of Thin Margins

Deep News
·
Feb 05

Great Wall Fund's Healthcare Investment Team Maintains Optimism on Medical Technology and Seeks New Rationale for Innovative Drugs

Deep News
·
Feb 05

UNITED LAB Shares Rise Nearly 3% as Its Self-Developed Innovative Drug UBT251 Injection Receives Clinical Trial Implied Permission for OSA Indication

Stock News
·
Feb 05

CMS (00867) Self-Developed Innovative Drug CMS-D017 Capsule Receives Clinical Trial Approval Notice for Complement-Mediated Kidney Diseases

Stock News
·
Feb 03

Zhuhai Rundu Pharmaceutical (002923.SZ): Approval and Market Launch of Class 1 Innovative Drug Norcoclaurine Hydrochloride Injection Remain Uncertain

Stock News
·
Feb 02

CMSC International Reiterates "Neutral" Rating on CSPC PHARMA (01093) as Chinese Innovative Drugs Enter Global Pipeline

Stock News
·
Feb 02

$18.5 Billion: New Record Set in Innovative Drug BD! Seize the Opportunity to Invest in Hong Kong Stock Connect's Undervalued Biotech Plays

Deep News
·
Feb 02

CMS (00867): Innovative Drug Ruxolitinib Phosphate Cream Approved in China, Marking First and Only Targeted Therapy for Vitiligo

Stock News
·
Jan 30

Up to $5.6 Billion! Innovative Drug BD Deals Continue Hot Streak, Seize the Window for HUABAO HANG SENG HONG KONG STOCK CONNECT INNOVATIVE DRUG SELECTION TRADING OPEN ENDED INDEX SECURITIES INVES (520880)

Deep News
·
Jan 30

HENGRUI PHARMA (01276) Marketing Application for New Indication of Innovative Drug Camrelizumab and Apatinib Combination Accepted

Stock News
·
Jan 29

China's Drug Administration Law Introduces Market Exclusivity Period System for First Time, Impacting Generic Drug Market

Deep News
·
Jan 29

Immunotech Biopharm Signs Cell Therapy Processing Agreement with Tasly

Reuters
·
Jan 27

Immunotech Biopharm (6978) and Tasly (600535.SH) Reach Cell Therapy Service Agreement

Bulletin Express
·
Jan 27

Multiple Innovative Drugs Issue First Prescriptions Under New National Reimbursement Drug List, Lowering Patient Access Barriers

Deep News
·
Jan 27